Target intelligence / Profile preview

Receptor-transporting protein 4 (RTP4)

Target
RTP4
Molecular classification
Transporter, Adapter protein, Interferon-stimulated gene product, Zinc finger protein
01

Overview

Receptor-transporting protein 4 (RTP4) is a cytoplasmic, membrane-associated protein primarily recognized for its role in promoting cell-surface expression of certain G protein-coupled receptors (notably in chemosensory, pain, and olfactory pathways) and as an interferon-stimulated gene involved in host immune defense. RTP4 is rapidly upregulated following type I interferon signaling during viral and parasitic infection. Mechanistically, RTP4 acts as a negative regulator of type I interferon responses by binding to the TANK-binding kinase 1 (TBK1) complex, thereby inhibiting phosphorylation (activation) of TBK1 and interferon-regulatory factor 3 (IRF3), ultimately suppressing the production of type I interferons and several interferon-stimulated genes. Studies in mouse models show that RTP4 modulation has effects on susceptibility to viral brain infections and malaria-induced neurological symptoms, suggesting it is a potential (but currently undrugged) target for immune modulation in infectious and inflammatory diseases.

Other names
28 kDa interferon-responsive protein3CxxC-type zinc finger protein 4IFRG28Z3CXXC4receptor (chemosensory) transporter protein 4zinc finger, 3CxxC-type 4
02

Mechanism of action

No direct drugs known. Biological mechanism involves RTP4 binding to TBK1 complex, inhibiting TBK1- and IRF3-mediated signaling, thereby dampening IFN-I production and interferon-stimulated gene response

03

Biological functions

Promotes cell-surface expression of G protein-coupled receptors (GPCRs) (including chemosensory receptors)Negative regulation of type I interferon (IFN-I) responseModulation of antiviral immune responsesRegulation of TBK1/IRF3 signaling in interferon pathways
04

Disease associations

Infection (notably viral infections: hepatitis C, West Nile virus)Malaria (host response to Plasmodium infection)Potential roles in neuroinflammation and immune-mediated neuropathology
05

Safety considerations

No specific drug safety concerns identifiedGenetic modulation may alter host immunity, with possible effects on viral pathogenesis or neuroinflammation
06

Biomarkers

Interferon responses (elevated RTP4 expression may indicate IFN pathway activation)Viral or malaria infection states (RTP4 is upregulated by interferon during infection)

Beyond the preview

Go deeper on Receptor-transporting protein 4 (RTP4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Receptor-transporting protein 4 (RTP4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call